| Jul 9 |
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
|
| Jul 2 |
Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024
|
| Jun 28 |
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
|
| Jun 25 |
Does Inspire Medical Systems (INSP) Hava Ample Growth Opportunity, Considering Low Market Share?
|
| Jun 24 |
Inspire Medical, ResMed decline following Lilly tirzepatide sleep apnea data
|
| Jun 24 |
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
|
| Jun 24 |
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
|
| Jun 24 |
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
| Jun 12 |
Inspire Medical Systems: A Post Q1 Assessment
|
| Jun 6 |
Why Is Inspire (INSP) Down 7.3% Since Last Earnings Report?
|
